This compound is primarily used in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a trifluoromethylthio group, is particularly valuable in the development of drugs targeting central nervous system disorders, such as antidepressants or antipsychotics. The chiral center in the molecule allows for the production of enantiomerically pure compounds, which is crucial for ensuring the efficacy and safety of the final drug product. Additionally, its unique chemical properties make it suitable for use in organic synthesis and medicinal chemistry research, where it aids in the discovery of new therapeutic agents.